Open AccessWhich is the Preferred Regimen for Non-Severe Clostridioides difficile Infection in Korea, Vancomycin or Metronidazole?
Author(s) -
Jieun Kim,
Jinyeong Kim,
Bongyoung Kim,
Hyunjoo Pai
Publication year - 2022
Publication title -
infection and chemotherapy
Language(s) - English
Resource type - Journals
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2022.0027
Subject(s) - metronidazole , fidaxomicin , medicine , vancomycin , regimen , adverse effect , clostridioides , antibiotics , intensive care medicine , microbiology and biotechnology , bacteria , genetics , biology , staphylococcus aureus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom